Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GSK And Reckitt Opting Out Of Pfizer's Consumer Business Sale Speaks Volumes

Executive Summary

Reckitt and GSK withdraw from negotiating on potential deals for with Pfizer's consumer business, leaving slim chances Pfizer will receive an acceptable offer from other drug firms mentioned as potential suitors for the business, which it has valued at around $20bn. A spin-off could move to the fore.


Related Content

Glaxo, Sanofi Look Far Afield For Consumer Health Growth
Glaxo, Sanofi Look Far Afield For Consumer Health Growth
Perrigo Finding Balance As Three-Legged Stool With Two Consumer Units, Rx Division
Bayer Seeks Stronger Footing In Consumer Health After 2017 Stumble
Reckitt At '2.0' On Consumer Expansion But Question No. 1 Remains, Potential Pfizer Business Bid?
GSK Rides Cold, Flu And Pain OTCs In Q4 While Allergy Carries Sanofi
J&J Consumer Makes 'Aggressive' Shift In Digital Sales To Drive Growth
Pfizer Déjà Vu: Is It Time To Sell The Consumer Health Business?
Big Pharma Set To Compete For German Merck's Consumer Health Unit
OTC Evolution For Prestige Brands Combines Near- And Long-Term Strategies


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts